Boston City Council Hears Expert Testimony on Kratom: A Substance "Slipping Through All the Silos"

Why it matters

Boston City Council held a formal hearing on kratom sales with testimony from physicians, public health officials, and grieving families — revealing that neither the Boston Public Health Commission nor Boston Police currently track kratom-related incidents despite widespread availability in the city.

The big picture

More than 20 Massachusetts communities have already enacted local kratom bans, and state legislation is pending on Beacon Hill. Boston, with nearly a million residents, could become the largest U.S. city to ban kratom — potentially pressuring state legislators and other major cities to act. The council hearing exposed a regulatory blind spot: kratom falls outside existing frameworks for tobacco, alcohol, and cannabis.

Key findings

• Over 20 cities and towns in Massachusetts have already banned kratom sales, with more considering bans
• Boston Public Health Commission (BPHC) called kratom a "serious emerging concern" and flagged contamination risks including salmonella and heavy metals in 7-OH products
• Neither Boston Police nor BPHC currently collect data on kratom-related incidents because it is undetectable in standard drug testing
• BPHC staff have worked with patients who self-manage opioid addiction with kratom — acknowledging it falls outside existing treatment silos
• The council previously banned synthetic cannabis (K2) in 2015, but kratom requires a separate ordinance because it binds to opioid receptors, not cannabinoid receptors
• Holly Trouville, whose 25-year-old son Tyrell died after ingesting a kratom seltzer in 2024, testified: the status quo is not an option

What they say

It is just made way too accessible. I think what has occurred in many ways is that it has slipped through all the silos we have created. We have a silo for tobacco and alcohol, we have a silo for cannabinoids — all of these supplements do not live under a silo. — Dr. Nonnie Estella, former President of Medical Staff, Lowell General Hospital

Bottom line

Boston City Council's kratom hearing exposed a critical regulatory gap: a potent opioid-like substance sold freely in convenience stores, with no local data collection and no existing ordinance to address it.